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Expression of the nm23-2/NDP kinase a gene in rat mammary and oral
carcinoma cells of varying metastatic potential
B.R. Henderson
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Summary Reduced expression of the putative metastasis-suppressor gene, nm23-1, has previously been
correlated with high tumour metastatic potential. The involvement of the related and proximally-located
nm23-2 gene in the suppression of tumour metastasis, however, has not yet been tested. In this study, we
compared nm23-2 RNA levels in cell lines derived from three independent rat mammary carcinomas. Northern
blot analysis revealed no correlation between nm23-2 RNA levels and metastatic potential in parent or clonal
cell lines derived from chemically-induced (MAT 13762, DMBA-8) or spontaneous (BCI) rat mammary
carcinomas. Cloning and sequencing of an nm23-2 cDNA from metastatic BCI cells demonstrated that the
predicted coding sequence of nm23-2 RNA in these cells was not inactivated by mutation. Further analysis
showed that the nm23-2 gene was not down-regulated in H-ras-transfected metastatic clones or other
metastatic cell lines derived from a spontaneous rat paraoral squamous cell carcinoma, BIO. The data do not
suggest a correlation between nm23-2 gene expression and metastasis-suppression in these tumours.
Cancer metastasis is a complex process in which tumour cells
of a primary neoplasm invade normal tissue, enter and
escape the vasculature, and generate secondary tumours or
metastases (reviewed in Fidler, 1990). The metastatic process
comprises sequential steps, each of which is likely to entail
the activation and/or repression of specific genes or gene
products, depending on the origin and type of tumour (Hart
et al., 1989; Fidler & Radinsky, 1990). nm23-1 is one such
gene reported to be down-regulated in metastatic cells of
different rodent tumours (Steeg et al., 1988a,b). The human
homologue of this gene, nm23-H1, encodes one sub-unit of
the enzyme NDP kinase (Gillies et al., 1991). The mouse
nm23-1 gene was demonstrated to reduce experimental
metastasis following transfection into mouse melanoma cells
(Leone et al., 1991), and subsequently was proposed to repre-
sent a putative 'metastasis-suppressor' gene (reviewed in
Liotta et al., 1991). Recent evidence indicates that the
structurally-related human nm23-H2 gene (Stahl et al., 1991),
encoding a second sub-unit of NDP kinase (Gillies et al.,
1991), co-localises with nm23-H1 to 17q21.3, a human
chromosomal region known to contain the locus for early-
onset familial breast-ovarian cancer and other genes involved
in tumourigenesis (Backer et al., 1993). The rat nm23-1
(NDP kinase ,B) and nm23-2 (NDP kinase a) genes also
co-localise to within 3 kbp in rat genomic DNA (Shimada et
al., 1993). While the nm23-1 genes have remained the focus
of intense investigation, comparatively little is known of
nm23-2 gene expression, despite the earlier proposal that the
human nm23-H2 gene also represented a metastasis suppres-
sor (Stahl et al., 1991). This study was therefore undertaken
to test the hypothesis that nm23-2 represents a metastasis-
suppressor gene. Rat nm23-2 cDNA was cloned and nm23-2
specific RNA levels were compared in cell lines derived from
independent rat mammary and oral carcinomas. Expression
of the rat nm23-2 gene did not strictly correlate with meta-
static potential in the tumour cells studied.
Materials and methods
Cell lines and culture
The tumour-forming ability and experimental and/or spon-
taneous metastatic potential of each cell line used in this
study was previously determined, either directly in this
laboratory or through kind collaboration with Dr J.R. Gib-
bins (Department of Pathology, University of Sydney).
Cytoplasmic RNA was prepared from cells at the same time
metastatic ability was assessed, and subsequently was utilised
in the Northern blots of this study. A brief description of the
cell lines is necessary to place the results from this study into
perspective.
Rat mammary carcinoma cell lines
The derivation and characteristics of cell lines derived from
the chemically-induced rat mammary adenocarcinomas
DMBA-8 and MAT 13762, have previously been described in
some detail (Ramshaw & Badenoch-Jones, 1985; Ramshaw et
al., 1986). The original parent cell line adapted from the
DMBA-8 tumour (named DMBA-8), is capable of forming
tumours but does not metastasise in syngeneic Fischer 344
rats (Ramshaw & Badenoch-Jones, 1985). A minimal in vivo
selection of DMBA-8-derived clones, resulted in cell lines
which were completely non-metastatic (NM4) or highly
metastatic (metastatic ascites, MA; metastatic clone 2, MC2)
when injected sub-cutaneously or via tail vein into host
animals (originally described in Ramshaw & Badenoch-Jones,
1985; Ramshaw et al., 1986; Dear et al., 1989). The MAT
13762 parent cell line, by contrast, was itself highly metas-
tatic in syngeneic Fischer 344 rats (originally described in
Ramshaw & Badenoch-Jones, 1985). A MAT 13762 6-
thioguanine-resistant variant (J-clone), however, maintained
some tumour-forming potential but was found to be con-
sistently incapable of metastasising in syngeneic host rats
(Ramshaw et al., 1982). The experimental metastatic poten-
tial ofeach of these cell lines was reassessed and re-confirmed
recently in syngeneic rats (Henderson et al., 1992), and RNA
was prepared directly from those batches of cultured cells for
use in the present study. The polyclonal parent cell line
adapted from a spontaneous and aggressive rat mammary
carcinoma, BC1 (first described by O'Grady et al., 1981), has
consistently displayed aggressive tumour-forming and
experimental and spontaneous metastatic potential in host
dark agouti rats. RNA was isolated for analysis from a
previous passage of BCl cells at the time their aggressive
malignant behaviour was confirmed (data reported in Gib-
bins et al., 1991).
Rat oral carcinomas
A5P/BlO is a clonal cell line obtained from a well-
differentiated, spontaneous epithelial oral tumour, which is
capable of tumour formation but does not metastasise in
syngeneic dark agouti rats (described recently in Gibbins et
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al., 1991). Co-transfection of A5P/B10 cells with plasmid
pEJ2 containing the Ha-ras oncogene, and pSV2neo DNA,
permitted the selection of cell lines which aquired metastatic
ability (K23, K28 and K29), as described in Gibbins et al.
(1991). Of these, K29 was the most aggressive tumour-
forming cell line. The anaplastic T952/F7 cell line was cloned
from a lymph node metastasis in an animal inoculated with
A5P/B10 cells co-transfected with pSV2neo plus BCI cell
genomic DNA (Gibbins et al., 1991). The non-metastatic
Y43BP cell line was obtained from a benign tumour pro-
duced by the inoculation of ASP/B10 cells co-transfected
with pSV2neo and normal lymphocyte DNA (Gibbins et al.,
1991). Somatic cell hybridisation in this laboratory of these
two cell lines and selection from a primary footpad tumour
resulted in generation of a highly metastatic cell line,
F4TQ2AF (described in Paine et al., 1992). Cytoplasmic
RNA was prepared from the cell lines described above (in
addition to primary rat embryo fibroblasts; REF) at the time
metastatic potential was assessed (tumour cells were
inoculated into footpads of syngeneic animals and lymph
node metastasis scored), the data of which is described in
Gibbins et al. (1991) and Paine et al. (1992). Cells and/or
cytoplasmic RNA at that time were generously supplied by
Dr J.R. Gibbins and Dr M. Paine. All cell lines used in this
study were determined to be mycooplasma negative.
cDNA cloning and sequencing
The human nm23-H2 gene encodes a protein identical to
human NDP kinase B (Stahl et al., 1991; Gillies et al., 1991),
which in rat cells corresponds to a protein named rat NDP
kinase a (Kimura et al., 1990). Rat nm23-2 (or NDP kinase
a) cDNA was cloned from a cDNA library synthesised from
metastatic BC1 rat mammary carcinoma cells (see Paine et
al., 1992), by screening with a 21 base 32P-labelled
oligonucleotide (nm23b; 5'AGATGGTCCATCCATCCAGT-
CAGTG-3') selected from the published rat NDP kinase oc
gene 3' untranslated region (Kimura et al., 1990) and using
standard techniques (Sambrook et al., 1989). DNA from
positive clones were purified and further screened by
polymerase chain reaction (PCR) using the forward primer
nm23a (5'-GCTTCTGCAGGACCATGGCC-3') which over-
laps the translation start site (Kimura et al., 1990), and
nm23b as reverse primer. A full-length (- 600 bp) PCR
product was cloned and sequenced using standard techniques
(Sambrook et al., 1989). Cloning and sequencing of rat
nm23-2 cDNA from a highly metastatic cell line ensured that
the mRNA detected by Northern blot analysis in these cells
was not structurally altered, but was likely to encode a
functional NDP kinase a peptide (Kimura et al., 1990).
Results
nm23-2 RNA levels in cell lines derivedfrom rat mammary
carcinomas
The non-metastatic DMBA-8 parent cell line, and non-
metastatic (NM4) or highly metastatic (MA, MC2) clonal
derivatives were tested for nm23-2 RNA expression by
Northern blot analysis (Figure la). Interestingly, of the
DMBA-8 tumour cell clones, only the non-metastatic (NM4)
cells expressed reduced levels of nm23-2 RNA relative to the
parent DMBA-8 cell line (see Figure 2 for quantitation). A
slightly reduced level of nm23-2 RNA (30% reduction) was
observed in metastatic MAT 13762 cells relative to a clonal
non-metastatic derivative, J-clone (Figures lb, 2). The BCI
cell line, derived from a spontaneous and highly aggressive
rat mammary carcinoma (O'Grady et al., 1981), also ex-
pressed the nm23-2 gene at a high level (Figures lb, 2).
Therefore, nm23-2 RNA levels did not strictly correlate with
metastatic potential in cell lines derived from three indepen-
dent rat mammary tumours. The 80 bp difference in size
between rat nm23-1 and nm23-2 cDNAs (Shimada et al.,
1993), permitted visual distinction of the two nm23 RNA
species in certain Northern blots employing less stringent
washing conditions (see Materials and methods). Under such
conditions, the nm23-1 gene was found to be as highly
expressed as nm23-2 in metastatic MAT 13762 cells (data not
shown).
The entire 600 bp nm23-2 cDNA cloned from metastatic
BCI cells was sequenced (primary sequence data not shown),
and despite a single base change in amino acid residue 55
(leucine; CTG to TTG), there was no alteration in the protein
coding sequence when compared to rat nm23-2 (NDP kinase
a) from normal tissue (see Kimura et al., 1990). This excludes
the possibility of mutational inactivation of the nm23-2/NDP
kinase a protein in the metastatic BCI cells studied.
Preliminary experiments designed to study the regulation
of the nm23-2 gene, revealed that nm23-2 RNA levels were
not modulated by serum starvation ofmetastatic MAT 13762
cells, or by treatment with foetal calf serum, cycloheximide
or phorbol ester (data not shown). The half-life of nm23-2
(and nm23-1) cytoplasmic RNA in MAT 13762 cells was
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Cytoplasmic RNA isolation and analysis
Total cytoplasmic RNA was isolated by the Nonidet P-40
lysis method and analysed by Northern blotting as previously
described (Henderson et al., 1992). To ensure specific detec-
tion of nm23-2 RNA, Northern blots were probed with
32P-labelled full-length rat nm23-2 cDNA under highly strin-
gent conditions (0.2 x SSC, 0.1% SDS at 65°C; conditions
recently demonstrated to give specific detection of rat nm23-1
or nm23-2, see Shimada et al., 1993). Alternatively, a 32p_
end-labelled oligonucleotide nm23b probe was employed; this
sequence is located in the 3' untranslated region of rat NDP
kinase a (nm23-2; Kimura et al., 1990), and does not cross-
hybridise with the related rat gene nm23-1 (Shimada et al.,
1993). Similar results were obtained with either probe. In
addition, under reduced stringency washing conditions
(2 x SSC, 0.1% SDS at 45°C), an additional band appeared
in certain blots, which was about 80 bases larger in size and
most likely corresponded to the rat nm23-1 mRNA (Shimada
et al., 1993). All filters were reprobed with glyceraldehyde
3-phosphate dehydrogenase (GAPDH; pHcGAP plasmid,
American Type Culture Collection) cDNA to control for
integrity and quantity of the RNA loaded.
nm23-2
GAPDH
Figure 1 Northern blot analysis. Ten fig cytoplasmic RNA was
loaded per lane of a 1% formaldehyde agarose gel, and equiva-
lent loading was confirmed by ethidium bromide staining. Filters
were probed with 32P-labelled nm23-2 or GAPDH cDNA. The
metastatic (MET) or tumour-forming (TUM) potential of each
cell line in syngeneic animals is indicated (see Materials and
methods). Samples are as follows: a, parent DMBA-8 cell line
and clonal derivatives, b, cell lines derived from MAT 13762 and
BC1 rat mammary carcinomas, with MA as reference, and c, rat
embryo fibroblasts (REF), including DMBA-8, NM4 cells for
reference.876 B.R. HENDERSON
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Figure 2 Comparison of relative nm23-2 RNA levels in different
rat mammary carcinoma cell lines. Relative intensities of nm23-2
RNA autoradiograph signals were quantitated by scanning den-
sitometry, setting DMBA-8 a value of 1, and normalised to
GAPDH signals. Columns, mean from at least two independent
experiments; bars, standard error. Cell lines and symbols are
described in legend to Figure 1.
calculated to be > 16 h by actinomycin D chase (data not
shown). Despite the stability of nm23 RNA transcripts, dex-
amethasone treatment which decreased the stability of
urokinase RNA in MAT 13762 cells (Henderson & Kefford,
1993), did not down-regulate nm23 gene expression. The
expression of the rat nm23-2/NDP kinase a gene and its
product were previously found to be tissue-specific (Kimura
et al., 1990). Therefore, we tested for any correlation between
nm23-2 gene expression and metastasis in other rat cell-types
and tumours.
nm23-2 RNA is highly expressed in rat embryofibroblasts
In contrast to nm23-1 RNA levels (Steeg et al., 1988b), the
nm23-2 gene was highly expressed in primary rat embryo
fibroblasts relative to non-metastatic DMBA-8 and NM4
cells (Figures lc, 2). Similar results were found with Rat-I
fibroblasts (data not shown). Moreover, mouse F9 embry-
onal carcinoma cells produced a level of nm23-2 RNA which
did not vary over time during induction of differentiation by
all-trans retinoic acid (data not shown). Collectively, these
data indicate that nm23-2 RNA is highly expressed in
different rodent embryo-derived cell types, possibly indepen-
dent of the state of differentiation.
nm23-2 gene expression in cell lines derivedfrom a rat oral
carcinoma
The H-ras oncogene is capable of inducing the tumourigenic
and metastatic phenotype in selected cell types (reviewed in
Hart et al., 1989; Dear & Kefford, 1990). Recently, transfec-
tion of a benign rat oral epithelial cell line, A5P/B10, with
the EJ-H-ras oncogene, resulted in the derivation of several
clonal cell lines which were metastatic in syngeneic animals
(Gibbins et al., 1991). nm23-2 RNA levels were assessed in
three of these malignant H-ras transfectants (K23, K28 and
K29) relative to the benign parent cell line (A5P/B10). As
shown in Figure 3, nm23-2 RNA levels were actually in-
creased by up to 3-fold in two of the metastatic derivatives,
when normalised to GAPDH signals. Similar results were
observed recently for combined nm23 RNA levels in human
metastatic colon cancers (Haut et al., 1991). Three other
transfected cell lines derived from A5P/B10 cell line (Y43PB,
T952/F7 and F4TQ2AF) displayed a modest increase in
nm23-2 RNA independent of metastatic ability (Figure 3).
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Figure 3 Comparison of relative nm23-2 RNA levels in cell lines
derived from the benign rat oral carcinoma, B10. Mean relative
intensities of nm23-2 RNA autoradiograph signals (relative to
GAPDH signals) were quantitated from Northern blots, setting
the benign parent cell line A5P/B10 a value of one. The A5P/B1O
derivatives include metastatic H-ras transfected cells (open bars)
and other transfected B10 cell lines (hatched bars), as described
in Materials and methods. The relative level of nm23-2 RNA
from BCI cells (black bar) was included as a reference. Whether
the cells are highly metastatic ( + ) or not (-), or transfected
with the EJ-H-ras oncogene, is clearly indicated.
Discussion
The proximally-linked genes, nm23-1 and nm23-2, have been
proposed to play a role in suppressing tumour metastasis in
humans and rodents (see Liotta et al., 1991; Stahl et al.,
1991). The two genes disclose different tissue-specific patterns
of expression in rats (Shimada et al., 1993), suggesting that
they can be independently regulated. This point is
emphasised by the earlier citation of unpublished data (Stahl
et al., 1991), indicating a stronger reduction of nm23-H2
RNA levels (than nm23-H1) in v-ki-ras transfected human
bronchial epithelial cells with increasing malignant
behaviour. The data presented in this study, however,
revealed no strict correlation between nm23-2 RNA levels
and metastatic ability in cell lines derived from chemically-
induced and spontaneous rat mammary carcinomas, or a
spontaneous rat oral carcinoma. In particular, induction of
metastatic competence by H-ras transfection of A5P/B1O oral
carcinoma cells was not accompanied by down-regulation of
the nm23-2 gene.
Radinsky et al. (1992) recently undertook a detailed
examination of nm23-1 RNA levels in a wide selection of
clones and hybrids from the same mouse K-1735 melanoma
originally described (Steeg et al., 1988a). Whilst these inves-
tigators observed the original trend of Steeg et al. (1988a)
using the clones C-19 and M-2, analysis of additional clones
and somatic cell hybrids did not reveal a correlation between
nm23-1 mRNA levels and metastatic potential. Moreover, in
contrast to earlier data suggesting an inverse correlation
between net nm23 RNA (Benilacqua et al., 1989; Hennessy et
al., 1991) and protein (Barnes et al., 1991) levels in invasive
human breast cancer, recent studies of nm23/NDP kinase
enzyme activity and protein levels reported no correlation
with lymph node metastasis in breast cancer (Lacombe et al.,
1991; Sastre-Garau et al., 1992). There are actually several
examples of human tumours in which it appears that nm23
protein is more highly expressed than in normal tissue, in-
cluding neuroblastoma (Hailat et al., 1991; Leone et al.,
1993), breast carcinoma, colon and cervical carcinoma
(Lacombe et al., 1991), and melanoma (Lacombe et al., 1991;
Florenes 1992). Therefore, neither nm23-1 nor nm23-2
mRNA levels appear to display a reproducible and strict
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inverse relationship with metastatic behaviour, at least in
those tumours so far studied in humans or rodents.
Does this preclude involvement of the nm23/NDP kinase
genes in metastasis suppression? Not necessarily. It must be
borne in mind that Backer et al. (1993) recently defined very
accurately the location of the human nm23-HI and nm23-H2
genes to chromosome 17q21.3, in a region known to harbour
several genes such as ERBB2, HOX2, RARA and PHB, that
undergo structural rearrangements and are thought to play a
role in tumourigenesis (see Backer et al., 1993 for details). In
this regard, it is of interest to learn that the nm23-HI gene
can undergo mutation in certain metastatic (but not non-
metastatic) colorectal adenocarcinomas (Wang et al., 1993).
In a separate investigation, Leone et al. (1993) observed a
coding sequence mutation in both nm23-H1 and nm23-H2
mRNAs in sub-populations of advanced neuroblastoma. One
might therefore envisage that at least in certain tumour types,
mutational inactivation of nm23/NDP kinase genes may cor-
relate and perhaps play an important role in the development
of tumour metastasis. In this study, a rat nm23-2 cDNA was
cloned from a single cell line (BC1) derived from a spon-
taneous and highly metastatic rat mammary carcinoma, and
sequenced. Despite a single nucleotide change compared to
normal rat NDP kinase x cDNA (Kimura et al., 1990), there
was no alteration to the amino acid coding sequence of
nm23-2 mRNA in these metastatic cells. The possibility of
mutational inactivation of nm23-2 mRNA in the other highly
metastatic rat cell lines studied here has yet to be excluded.
Despite these correlative arguments, the only strong
evidence favouring a causal role for nm23-1/NDP kinase in
preventing tumour cell metastasis is based on transfection
studies of metastatic K-1735 mouse melanoma cells (Leone et
al., 1991). Clearly, such gene transfection studies must be
applied to other model systems, and should perhaps be per-
formed in conjunction with antisense RNA experiments,
wherein nm23-1 or nm23-2 RNA might be silenced in normal
cell types prior to testing for 'induction' of metastatic com-
petence. In view of the multiple levels of nm23 gene regula-
tion and the absolute need to go beyond correlative studies,
well-defined experiments of the type described above are
likely to better address the potential involvement of nm23-1
and nm23-2 in metastasis.
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